Home Dermatology PDF: Spesolimab, A Novel Interleukin-36 Inhibitor for Generalized Pustular Psoriasis Flares in Adult Patients
Article
PDF: Spesolimab, A Novel Interleukin-36 Inhibitor for Generalized Pustular Psoriasis Flares in Adult Patients
$1.99
PDF Download: Explore the groundbreaking role of Spesolimab, a novel interleukin-36 inhibitor, in treating Generalized Pustular Psoriasis flares in adults. This article presents key findings from phase 1 and 2 clinical trials, emphasizing Spesolimab’s effectiveness and safety.
Read online:
Spesolimab, A Novel Interleukin-36 Inhibitor for Generalized Pustular Psoriasis Flares in Adult Patients
Related products
-
Article
PDF: Real-World Efficacy of Azelaic Acid 15% Gel for the Reduction of Inflammatory Lesions of Rosacea
$1.99 Add to cart -
Article
PDF: Hydrogen Peroxide Topical Solution, 40% for the Treatment of Seborrheic Keratoses
$1.99 Add to cart -
Article
PDF: Update on Drugs & Devices: September – October 2019
$1.99 Add to cart -
Article
PDF: Non-Invasive Gene Expression Testing to Rule Out Melanoma
$1.99 Add to cart
